摘要
目的系统评价高敏C反应蛋白(hs-CRP)与患者行冠状动脉造影(CAG)或经皮冠状动脉介入治疗(PCI)术后发生对比剂肾病(CIN)的相关性。方法检索PubMed、Web of Science、中国生物医学文献数据库、中国知网、万方数据等数据库,选取从建库到2021年3月7日发表的CIN组和非CIN组CAG或PCI患者术前hs-CRP水平的研究。获得相关数据后,使用RevMan 5.3和Stata 12.0软件进行Meta分析。结果最终纳入了14项相关研究,包括11885例CAG或PCI治疗患者(1034例CIN患者和10851例非CIN患者)。Meta分析结果显示,CIN组hs-CRP水平显著高于非CIN组(WMD=3.77,95%CI:2.80~4.74,P<0.001,I2=93%),CAG或PCI术前hs-CRP水平较高的患者更容易发生CIN。敏感性分析表明该研究的结果具有较好的稳定性,亚组分析的结果表明样本量、研究人群、地理位置和CIN的定义的差异具有统计学意义。结论现有证据显示,高hs-CRP水平是CAG或PCI术后CIN的危险因素,然而仍需要大样本试验来支持这一结论。
Objective To systematically evaluate the correlation of high sensitivity C-reactive protein(hs-CRP)with contrast-induced nephropathy(CIN)in patients following coronary angiography(CAG)or percutaneous coronary intervention(PCI).Methods PubMed,web of science,CBM,CNKI and Wanfang Data were searched for studies on hs-CRP levels in patients undergoing CAG or PCI patients from the incipience of the database to March 7,2021.Meta-analysis was performed by RevMan 5.3 and Stata 12.0 software.Results Fourteen related studies were included involving 11885 patients undergoing CAG or PCI(1034 cases with CIN and 10851 cases without CIN).The results of meta-analysis showed that the level of hs-CRP in CIN group was significantly higher than that in non-CIN group(WMD=3.77,95%CI:2.80—4.74,P<0.001,I²=93%),patients with higher levels of hs-CRP before CAG or PCI were more likely to develop CIN.Sensitivity analysis shows that the results of this study had good stability.The results of subgroup analysis show that the differences in sample size,study population,geographical location and the definition of CIN were statistically significant.Conclusion Available evidence shows that high hs-CRP level is a risk factor for CIN in patients undergoing CAG or PCI,large sample trials are still needed to support this conclusion.
作者
李淑君
陈敏
孙悦东
田香玉
王子龙
周新玲
张霞
周发展
Li Shujun;Chen Min;Sun Yuedong;Tian Xiangyu;Wang Zilong;Zhou Xinling;Zhang Xia;Zhou Fazhan(Shandong First Medical University(Shandong Academy of Medical Sciences),Jinan 250117,China;Internet Diagnosis and Treatment Center,the Affiliated Taian Central Hospital of Qingdao University,Taian 271000,China;Department of Cardiology,the Affiliated Taian City Central Hospital of Qingdao University,Taian 271000,China;Department of Gastroenterology,the Affiliated Taian City Central Hospital of Qingdao University,Taian 271000,China)
出处
《中华全科医师杂志》
2022年第6期547-553,共7页
Chinese Journal of General Practitioners
基金
泰安市科技发展计划(2019NS115)。
关键词
C反应蛋白质
高敏
冠状血管造影术
经皮冠状动脉介入治疗
对比剂肾病
META分析
High sensitivity C-reactive protein
Coronary angiography
Percutaneous coronary intervention
Contrast-induced nephropathy
Meta analysis